XM does not provide services to residents of the United States of America.

XM does not provide services to residents of the United States of America.
C
C

Cigna

News

Reuters - 4 days ago

US employers expect nearly 6% spike in health insurance costs in 2025, Mercer says

US employers expect nearly 6% spike in health insurance costs in 2025, Mercer says By Amina Niasse NEW YORK, Sept 12 (Reuters) - U.S. employers expect health insurance costs to rise an average 5.8% in 2025, largely due to increased cost of medical services as well as higher use, according to a survey released by consulting firm Mercer on Thursday.
C
Reuters - 4 days ago

Cigna Healthcare Makes Virtual Care Even Easier And More Convenient With New E-Treatment Option From MDLIVE

BRIEF-Cigna Healthcare Makes Virtual Care Even Easier And More Convenient With New E-Treatment Option From MDLIVE Sept 12 (Reuters) - Cigna Group CI.N : CIGNA HEALTHCARE MAKES VIRTUAL CARE EVEN EASIER AND MORE CONVENIENT WITH NEW E-TREATMENT OPTION FROM MDLIVE Source text for Eikon: ID:nPn2lrgZga Further company coverage: CI.N
C
Reuters - 6 days ago

UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year

UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year By Patrick Wingrove Sept 10 (Reuters) - UnitedHealth Group UNH.N said on Tuesday it will remove AbbVie’s ABBV.N blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement as of Jan. 1, 2025, and recommend less expensive biosimilar versions of the medicine instead.
A
C
P
T
Reuters - 6 days ago

Portion of insured Americans was 92% in 2023, Census data shows

UPDATE 2-Portion of insured Americans was 92% in 2023, Census data shows Adds context on data in paragraph 3 and Medicare figure in paragraph 6 By Amina Niasse NEW YORK, Sept 10 (Reuters) - The portion of Americans who had health insurance for all or part of the year in 2023 was 92%, compared with 92.1% for all or part of 2022 according to a report released by the Census Bureau on Tuesday.
C
Reuters - 6 days ago

Proportion of Americans with health insurance was at 92% in 2023, Census data shows

Proportion of Americans with health insurance was at 92% in 2023, Census data shows NEW YORK, Sept 10 (Reuters) - The portion of Americans who had health insurance for all or part of the year fell slightly in 2023 to 92%, compared with 92.1% for all or part of 2022 according to a report released by the Census Bureau on Tuesday. The rate of Americans who are uninsured is set to rise to 8.9% over the next decade from 7.7% in 2024, the Congressional Budget Office said in a separate report released
C
Reuters - 6 days ago

More than 49 million in US covered by ACA over the past decade

More than 49 million in US covered by ACA over the past decade By Amina Niasse NEW YORK, Sept 10 (Reuters) - One in seven Americans have signed up for health insurance coverage through Affordable Care Act marketplaces since their 2014 launch, according to data released on Tuesday by the U.S. Department of the Treasury. A total of 49.4 million Americans have signed up for the plans, often referred to as Obamacare, with enrollment reaching a high of 20.8 million people in 2024, the agency said.
C
Reuters - 1 week ago

Biden administration finalizes rule to strengthen mental health parity law

Biden administration finalizes rule to strengthen mental health parity law By Amina Niasse NEW YORK, Sept 9 (Reuters) - The Biden Administration on Monday said it had finalized regulation to help ensure the 175 million Americans with private health insurance have access to affordable mental health services. The 2008 Mental Health Parity and Addiction Equity Act already requires insurers and corporate-backed health plans to provide access and payment structures for mental health care services on
C
Reuters - 3 weeks ago

Cigna to remove AbbVie's Humira from some drug reimbursement lists next year

Cigna to remove AbbVie's Humira from some drug reimbursement lists next year By Patrick Wingrove Aug 26 (Reuters) - Cigna CI.N said on Monday it will remove AbbVie’s ABBV.N blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025, and recommend less pricey biosimilar versions of the medicine instead.
A
C
P
T
Reuters - 4 weeks ago

U.S. Agree Realty, Global Payments, Snowflake

U.S. RESEARCH ROUNDUP- Agree Realty, Global Payments, Snowflake Aug 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Agree Realty, Global Payments and Snowflake on Wednesday. HIGHLIGHTS * Agree Realty Corp ADC.N : Raymond James raises target price to $81 from $70 * Coinbase Global Inc COIN.O : Jefferies cuts target price to $220 from $245 * Global Payments Inc GPN.N : Jefferies raises target price to $130 from $120
A
B
C
C
P
V
E
G
M
K
L
Reuters - 4 weeks ago

Venture capital firms making bets on maternal health

FOCUS-Venture capital firms making bets on maternal health By Amina Niasse NEW YORK, Aug 19 (Reuters) - After working as a doula for 10 years, Kortny Feutardo took her first Maryland Medicaid patient in January, providing the new mom with care coordination and counseling. Feutardo is one of many providers benefiting from growing investment in the maternal and neonatal health sector .
C
Reuters - 1 month ago

The Cigna Group Foundation Launches Grant Program To Improve Veteran Mental Health

BRIEF-The Cigna Group Foundation Launches Grant Program To Improve Veteran Mental Health Aug 12 (Reuters) - Cigna Group CI.N : THE CIGNA GROUP FOUNDATION LAUNCHES GRANT PROGRAM TO IMPROVE VETERAN MENTAL HEALTH Source text for Eikon: ID:nPn2HqD7a Further company coverage: CI.N ( Reuters.Briefs@thomsonreuters.com )
C
Reuters - 1 month ago

U.S. Booking Holdings, Doordash, Vertex Pharmaceuticals

U.S. RESEARCH ROUNDUP- Booking Holdings, Doordash, Vertex Pharmaceuticals Aug 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Booking Holdings, Doordash and Vertex Pharmaceuticals, on Monday. HIGHLIGHTS * Academy Sports and Outdoors Inc ASO.O : JP Morgan cuts to neutral from overweight * Booking Holdings Inc BKNG.O : Jefferies cuts target price to $4350 from $4650 * Doordash DASH.O : D.A.
A
B
C
C
C
C
E
V
E
A
B
C
C
C
C
Reuters - 2 months ago

Cigna falls after unchanged annual forecast despite profit beat

BUZZ-Cigna falls after unchanged annual forecast despite profit beat ** Shares of health insurer Cigna fall 4.8% to $331.80 ** Set for biggest one-day pct. fall since Nov. 2023 ** Co maintains its annual profit forecast after Q2 profit beat ** The lack of forecast raise despite the beat will be likely viewed as a modest disappointment - Leerink Partners ** Brokerage expects investors to keenly focus on determining if this resulted from more prudent posturing or a synthetic guide-down of the seco
C
Reuters - 2 months ago

Health insurer Cigna's cautious annual forecast spooks investors, shares fall

UPDATE 2-Health insurer Cigna's cautious annual forecast spooks investors, shares fall New throughout, adds details, background, analyst comments, updates share price By Amina Niasse and Sriparna Roy Aug 1 (Reuters) - Cigna CI.N took a cautious stance on its full-year profit outlook on Thursday despite reporting lower-than-feared medical costs in the second quarter and beating Wall Street's profit estimates, and the health insurer's shares fell more than 4%.
C
Reuters - 2 months ago

Fed nods to cut, chips rebound, BoE up next

MORNING BID AMERICAS-Fed nods to cut, chips rebound, BoE up next A look at the day ahead in U.S. and global markets from Mike Dolan The Federal Reserve left Wall Street with little doubt about a first U.S. interest rate cut in seven weeks' time, but multiple cross-currents from the earnings season , Japan and China, and domestic politics all make for a noisy start to August.
A
A
A
B
C
G
I
N
R
U
X
M
J
U
U
U
F
E
W
A
M
Reuters - 2 months ago

Cigna beats profit estimates on lower-than-expected costs, pharmacy benefit boost

Cigna beats profit estimates on lower-than-expected costs, pharmacy benefit boost Aug 1 (Reuters) - Cigna CI.N reported a second-quarter profit on Thursday that beat Wall Street estimates, helped by lower-than-expected medical costs and strength in its pharmacy benefit management unit. The industry has been contending with elevated medical costs since late last year, as older adults catch up on delayed procedures, and lower-than-expected payments from the government for managing healthcare for p
C
Reuters - 2 months ago

What to Watch in the Day Ahead - Thursday, August 1

What to Watch in the Day Ahead - Thursday, August 1 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT Apple is expected to report a rise in third-quarter revenue, helped by higher iPad sales from new launches and strength in its services business.
A
A
B
C
I
K
V
M
B
Reuters - 2 months ago

Humana slides on higher medical care use; other health insurers fall

BUZZ-Humana slides on higher medical care use; other health insurers fall Updates ** Shares of health insurer Humana HUM.N fall 6 .4% to $378 .63 , their biggest one-day loss pct since April ** Co reports higher-than-anticipated inpatient admissions - hospitalizations that require overnight stay - in second half of Q2 ** We continue to assess the durability of the higher admissions - HUM ** Shares of other health insurers also fall ** Shares of UnitedHealth UNH.N dip 1.2%, Elevance ELV.N down 1
C
Reuters - 2 months ago

Cigna Group <CI.N> expected to post earnings of $6.41 a share - Earnings Preview

Cigna Group expected to post earnings of $6.41 a share - Earnings Preview Cigna Group CI.N , CI is expected to show a rise in quarterly revenue when it reports results on August 1 for the period ending June 30 2024 The Bloomfield Connecticut-based company is expected to report a 20.0% increase in revenue to $58.329 billion from $48.62 billion a year ago, according to the mean estimate from 16 analysts, based on LSEG data.
C
Reuters - 2 months ago

AbbVie lifts 2024 profit forecast, shares hit record high

UPDATE 2-AbbVie lifts 2024 profit forecast, shares hit record high Adds information from investor call throughout, updates shares in paragraph 3 By Leroy Leo and Patrick Wingrove July 25 (Reuters) - AbbVie ABBV.N increased its profit forecast for 2024 on Thursday after reporting strong sales of immunology drugs and quarterly results that exceeded Wall Street expectations, sending its shares to a record high.
C

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.